· For research use only. Not for human consumption.
For research use only. Not for human consumption.
GLP-1, GLP-2, and GLP-3 — they sound almost identical, but they’re actually very different compounds. If you’re trying to understand the difference between GLP-1 vs GLP-2 vs GLP-3, you’re not alone. The naming is confusing, and the science doesn’t always help.
Here’s the simple version: GLP-1 and GLP-2 are related hormones your body naturally makes. GLP-3 is a newer research compound that targets multiple receptor systems at once. Each one works differently, targets different parts of the body, and is studied for different reasons.
Let’s break down GLP-1 vs GLP-2 vs GLP-3 in plain English so you can understand what makes each one unique. For research use only — not for human consumption.
TL;DR: GLP-1 targets metabolic signaling pathways, GLP-2 focuses on intestinal biology, and GLP-3 is a triple agonist that activates three receptor types simultaneously. They come from different origins and are studied for different research applications. All are sold for research use only.
GLP-1 vs GLP-2 vs GLP-3: A Quick Overview
Before diving into the details, here’s the big picture. Understanding the difference between GLP-1 vs GLP-2 vs GLP-3 starts with knowing where each one comes from and what it targets:
- GLP-1 (Glucagon-Like Peptide-1): A natural hormone made in your gut after eating. GLP-1 receptor agonist analogs are synthetic versions that researchers study for metabolic signaling pathways
- GLP-2 (Glucagon-Like Peptide-2): The “sister” of GLP-1 — made from the same parent molecule but focused on intestinal biology and gut barrier research
- GLP-3: A research compound classified as a triple agonist — it targets three different receptor types at once. Think of it as a master key that opens three different locks
What Is GLP-1 and How Does It Work?
GLP-1 stands for Glucagon-Like Peptide-1. Your body makes it naturally in cells lining your small intestine, especially after you eat a meal. It’s part of a system called the “incretin” pathway — a signaling system that helps your body respond to food.
When researchers talk about GLP-1 receptor agonist analogs, they mean synthetic versions designed to interact with GLP-1 receptors. These receptors are found in many tissues throughout the body. Published research by Holst in Physiological Reviews (2007) described the GLP-1 system as one of the most studied incretin pathways in preclinical and clinical research. (Holst JJ, Physiological Reviews, 2007)
GLP-1 research focuses on metabolic signaling — how cells communicate about energy, nutrients, and metabolic processes. Alpha Peptides carries GLP-1 SM for research applications.
What Is GLP-2 and How Is It Different?
GLP-2 comes from the same parent molecule as GLP-1 — a larger protein called proglucagon. Think of proglucagon as a long ribbon that gets cut into several different pieces. GLP-1 and GLP-2 are two of those pieces, but they do very different things.
While GLP-1 research focuses on metabolic signaling, GLP-2 research focuses on intestinal biology. GLP-2 receptors are primarily found in the gut — specifically in the epithelial cells that line your intestines.
Published research by Drucker and colleagues in PNAS (1996) was among the earliest to characterize GLP-2’s distinct biological properties in intestinal models. (Drucker DJ et al., PNAS, 1996)
Alpha Peptides carries GLP-2 TZ for research use. You can review quality documentation on our COAs page.
Drucker and colleagues published landmark research in PNAS (1996) demonstrating that GLP-2 had distinct biological properties from GLP-1, particularly in intestinal epithelial models. This established GLP-2 as an independent research target separate from the broader GLP-1 incretin pathway. (PMID: 8598044)
What Is GLP-3 and Why Is It Called a Triple Agonist?
Now here’s where things get really interesting. GLP-3 is fundamentally different from GLP-1 and GLP-2.
While GLP-1 and GLP-2 each target one specific receptor type, GLP-3 is designed to target three receptor types simultaneously. In research terminology, it’s called a “triple agonist” — “agonist” means something that activates a receptor, and “triple” means it activates three different ones.
Think of it this way:
- GLP-1 analog = a key that opens one specific door
- GLP-2 analog = a different key that opens a different door
- GLP-3 (triple agonist) = a master key designed to open three doors at once
The three receptor targets that GLP-3 interacts with include GLP-1 receptors, GIP receptors (gastric inhibitory polypeptide — another incretin hormone), and glucagon receptors. This multi-target approach is a newer area of preclinical research.
Alpha Peptides carries GLP-3 RT for research applications.
GLP-1 vs GLP-2 vs GLP-3: Side-by-Side Comparison
Here’s a simple breakdown of how GLP-1 vs GLP-2 vs GLP-3 compare across the key factors researchers care about:
- Origin: GLP-1 and GLP-2 are derived from proglucagon (natural hormone). GLP-3 is a synthetic multi-target research compound
- Receptor targets: GLP-1 targets GLP-1R. GLP-2 targets GLP-2R. GLP-3 targets GLP-1R, GIPR, and glucagon receptors
- Research focus: GLP-1 = metabolic signaling. GLP-2 = intestinal biology. GLP-3 = multi-pathway metabolic research
- Classification: GLP-1 and GLP-2 are single agonists. GLP-3 is a triple agonist
- Research stage: GLP-1 has the longest research history. GLP-2 has significant published data. GLP-3 is a newer research area
All three are available from Alpha Peptides: GLP-1 SM, GLP-2 TZ, and GLP-3 RT. Browse the full catalog at alpha-peptides.com/shop.
Frequently Asked Questions About GLP-1, GLP-2, and GLP-3
Are GLP-1 and GLP-2 related to each other?
Yes. GLP-1 and GLP-2 both come from the same parent molecule called proglucagon. Your body cuts proglucagon into several smaller pieces, and GLP-1 and GLP-2 are two of those pieces. Despite their shared origin, they target different receptors and are studied for different biological processes.
Is GLP-3 related to GLP-1 and GLP-2?
Not in the same way. While the name suggests a progression (GLP-1, GLP-2, GLP-3), GLP-3 is not a naturally occurring incretin hormone like the other two. It’s a synthetic research compound designed as a triple agonist — meaning it targets three receptor types at once, including the GLP-1 receptor.
Which GLP compound has the most published research?
GLP-1 has the longest and most extensive research history, with published studies dating back decades. GLP-2 also has significant preclinical and clinical data. GLP-3 represents a newer research area with a growing but more recent publication record.
Related reading: What Is GLP-1? A Beginner’s Guide | What Is GLP-2? A Simple Introduction | What Is GLP-3? Understanding the Triple Agonist
For research use only. Not for human consumption. GLP-1, GLP-2, and GLP-3 research compounds are experimental with varying levels of clinical development. All information on this page is provided for educational purposes relating to laboratory and preclinical research. It does not constitute medical advice.
